Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly

Ove Talsnes, Fredrik Hjelmstedt, Ola E Dahl, Are Hugo Pripp, Olav Reikerås, Ove Talsnes, Fredrik Hjelmstedt, Ola E Dahl, Are Hugo Pripp, Olav Reikerås

Abstract

Hip fracture, a moderate musculoskeletal trauma, is associated with a high postoperative mortality. Most patients are elderly, with comorbid conditions and often with heart disease. The objective of this study was to find out if clinical parameters and analyses of specific muscle enzymes could predict three month postoperative mortality. A total of 302 patients above 75 years of age with hip fracture were consecutively enrolled. Baseline information on age, sex and comorbidity assessed with the American Society of Anesthesiologists (ASA) score was obtained before surgery. Creatine kinase (CK), myocardium-specific creatine kinase (CK-MB) and troponin T (TnT) were analysed from venous blood, collected the day before surgery (-1) and postoperatively, within 24 hours (0) and on days one (+1) and four (+4). The overall three month mortality was 19.5%. Multivariate analyses showed that age, male sex and comorbidity (ASA) correlated with mortality (p = 0.027, p = 0.002, p < 0.001, respectively). Surgery induced a two- to threefold increase of CK and CK-MB but without any correlation with mortality. However, high TnT levels >0.04 μg/l correlated significantly with death (days -1, +1 and +4, p = 0.003, p = 0.005 and p = 0.003, respectively). Multivariate analyses, adjusted for age, sex and ASA category, confirmed this correlation (day +4, p = 0.008). Thus, in elderly patients with comorbidities undergoing hip fracture surgery information on sex, age, ASA category and postoperative laboratory analyses on TnT provide the clinicians with useful information on patients at risk of fatal outcome.

Figures

Fig. 1
Fig. 1
Mean and 95% confidence intervals for troponin T, creatine kinase (CK), myocardium-specific creatine kinase (CK-MB) and ratio of CK-MB to CK before surgery, perioperatively and 1 and 4 days after surgery for 3-month mortality. Statistical significance (p < 0.05) between mortality groups is indicated by an asterisk. Statistically significant (p < 0.05) differences between before surgery and during follow-up are indicated by the connecting lines. Day −1 1 day before surgery, day 0 within 24 h after the operation, day +1 24–48 h postoperatively, day +4 4 days after surgery

References

    1. Bjørgul K, Reikerås O. Incidence of hip fracture in southeastern Norway: a study of 1,730 cervical and trochanteric fractures. Int Orthop. 2007;31(5):665–669. doi: 10.1007/s00264-006-0251-3.
    1. Haentjens P, Magaziner J, Colón-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380–390.
    1. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633–1650. doi: 10.1007/s00198-009-0920-3.
    1. Hagino T, Sato E, Tonotsuka H, Ochiai S, Tokai M, Hamada Y. Prediction of ambulation prognosis in the elderly after hip fracture. Int Orthop. 2006;30(5):315–319. doi: 10.1007/s00264-006-0086-y.
    1. Carretta E, Bochicchio V, Rucci P, Fabbri G, Laus M, Fantini MP. Hip fracture: effectiveness of early surgery to prevent 30-day mortality. Int Orthop. 2010
    1. Nettleman MD, Alsip J, Schrader M, Schulte M. Predictors of mortality after acute hip fracture. J Gen Intern Med. 1996;11(12):765–767. doi: 10.1007/BF02598997.
    1. Lucreziotti S, Foroni C, Fiorentini C. Perioperative myocardial infarction in noncardiac surgery: the diagnostic and prognostic role of cardiac troponins. J Intern Med. 2002;252(1):11–20. doi: 10.1046/j.1365-2796.2002.01006.x.
    1. el Allaf M, Chapelle JP, el Allaf D, Adam A, Faymonville ME, Laurent P, Heusghem C. Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clin Chem. 1986;32(2):291–295.
    1. Wolfson D, Lindberg E, Su L, Farber SJ, Dubin SB. Three rapid immunoassays for the determination of creatine kinase MB: an analytical, clinical, and interpretive evaluation. Am Heart J. 1991;122(4 Pt 1):958–964. doi: 10.1016/0002-8703(91)90458-T.
    1. Fisher AA, Southcott EN, Goh SL, Srikusalanukul W, Hickman PE, Davis MW, Potter JM, Budge MM, Smith PN. Elevated serum cardiac troponin I in older patients with hip fracture: incidence and prognostic significance. Arch Orthop Trauma Surg. 2008;128(10):1073–1079. doi: 10.1007/s00402-007-0554-x.
    1. Kim LJ, Martinez EA, Faraday N, Dorman T, Fleisher LA, Perler BA, Williams GM, Chan D, Pronovost PJ. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation. 2002;106(18):2366–2371. doi: 10.1161/.
    1. Alpert JS, Thygesen K. A new global definition of myocardial infarction for the 21st century. Pol Arch Med Wewn. 2007;117(11–12):485–486.
    1. Chong C, Lam Q, Ryan J, Sinnappu R, Lim WK. Impact of troponin I on long term mortality after emergency orthopaedic surgery in older patients. Intern Med J. 2009
    1. Chong CP, Lam QT, Ryan JE, Sinnappu RN, Lim WK. Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients. Age Ageing. 2009;38(2):168–174. doi: 10.1093/ageing/afn231.
    1. Nesher N, Alghamdi AA, Singh SK, Sever JY, Christakis GT, Goldman BS, Cohen GN, Moussa F, Fremes SE. Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg. 2008;85(4):1348–1354. doi: 10.1016/j.athoracsur.2007.12.077.
    1. American Society of Anesthesiologists New classification of physical status. Anesthesiology. 1963;24:111.
    1. Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am. 2005;87(3):483–489. doi: 10.2106/JBJS.D.01796.
    1. Paksima N, Koval KJ, Aharanoff G, Walsh M, Kubiak EN, Zuckerman JD, Egol KA. Predictors of mortality after hip fracture: a 10-year prospective study. Bull NYU Hosp Jt Dis. 2008;66(2):111–117.
    1. Verbeek DO, Ponsen KJ, Goslings JC, Heetveld MJ. Effect of surgical delay on outcome in hip fracture patients: a retrospective multivariate analysis of 192 patients. Int Orthop. 2008;32(1):13–18. doi: 10.1007/s00264-006-0290-9.
    1. Bergqvist D, Fredin H. Pulmonary embolism and mortality in patients with fractured hips—a prospective consecutive series. Eur J Surg. 1991;157(10):571–574.
    1. Gruber UF. Prevention of fatal pulmonary embolism in patients with fractures of the neck of the femur. Surg Gynecol Obstet. 1985;161(1):37–42.
    1. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med. 1990;323(26):1781–1788. doi: 10.1056/NEJM199012273232601.
    1. Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, Krupski WC. Perioperative myocardial ischemia in patients undergoing noncardiac surgery–I: incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol. 1991;17(4):843–850. doi: 10.1016/0735-1097(91)90863-5.
    1. Wukich DK, Callaghan JJ, Graeber GM, Martyak T, Lyon JJ. Operative treatment of acute hip fractures: its effect on serum creatine kinase, lactate dehydrogenase and their isoenzymes. J Trauma. 1989;29(3):375–379. doi: 10.1097/00005373-198903000-00017.
    1. Wukich DK, Callaghan JJ, Graeber GM, Martyak T, Savory CG, Lyon JJ. Cardiac isoenzyme values after total joint arthroplasty. Clin Orthop Relat Res. 1989;242:232–240.
    1. Cohen RG, Katz JA, Skrepnik NV. The relationship between skeletal muscle serum markers and primary THA: a pilot study. Clin Orthop Relat Res. 2009;467(7):1747–1752. doi: 10.1007/s11999-009-0809-7.
    1. Chedrawy E, Hall R, Nedelcu V. Postoperative elevation of creatine kinase (CK-MB): does it contribute to diagnosis of myocardial infarction? Can J Anaesth. 1997;44(8):843–848. doi: 10.1007/BF03013161.
    1. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation. 2006;113(8):1071–1078. doi: 10.1161/CIRCULATIONAHA.105.570762.
    1. Ausset S, Minville V, Marquis C, Fourcade O, Rosencher N, Benhamou D, Auroy Y. Postoperative myocardial damages after hip fracture repair are frequent and associated with a poor cardiac outcome: a three-hospital study. Age Ageing. 2009;38(4):473–476. doi: 10.1093/ageing/afp043.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever